Salute e Benessere

Report from Orexo´s extraordinary general meeting

Remuneration to the board of directors Remuneration to the board of directors The extraordinary general meeting also resolved, in accordance with the nomination committee's proposal, that the remuneration to the members of the board of directors and the committees resolved at the annual general meeting on18 April 2023shall continue to apply and shall, if applicable, be distributed pro rata to the chairman and the ordinary members of the board of directors, respectively, elected by each...
PR Newswire
26/10/2023

KFSH&RC Unveils its Cutting-Edge Approach to Elevating the Patient Treatment…

KFSH&RC has achieved substantial advancements in streamlining the patient admission process through the 'Ehalat' service. This automated platform simplifies medical referrals and fosters collaboration with both public and private healthcare entities. Additionally, it empowers users to submit medical reports, compile personal data, and access their medical history—all within a unified service, eliminating the necessity for in-person visits to the hospital. This not only simplifies the...
Nasdaq GlobeNewswire
26/10/2023

Cellular Nutrition Market to Reach US$ 1,182.4 Million by 2033 Driven by Rising…

The worldwide cellular nutrition market is valued at US$ 586.2 million in 2023 and is anticipated to reach US$ 1,182.4 million by 2033. Over the assessment period, global cellular nutrition demand is likely to increase at a CAGR of 7.2%. The worldwide cellular nutrition market is valued at US$ 586.2 million in 2023 and is anticipated to reach US$ 1,182.4 million by 2033. Over the assessment period, global cellular nutrition demand is likely to increase at a CAGR of 7.2%. Demand is...
PR Newswire
26/10/2023

ZEISS continues to expand its clinical workflows and digital portfolio…

ZEISS Cataract Workflow showcases surgical planning and treatment enhancements to support a better patient experience ZEISS Cataract Workflow showcases surgical planning and treatment enhancements to support a better patient experience Today, ZEISS announces the510kclearance of the ZEISS VISULAS yag laser by the Food and Drug Administration (FDA) in the US. The ZEISS VISULAS yag provides a precise and compact laser workstation for safe and effective posterior capsulotomy and...
PR Newswire
26/10/2023

Rhino Rescue to Unveil Innovative Emergency Products at 88th CMEF

Rhino Rescue's ADV-PRO pneumothorax needle stands out as a flagship product in the company's portfolio. With an impressively quick application time of just four seconds, this needle is remarkably user-friendly. Its design guarantees consistent operation times, irrespective of the user's familiarity with the product. Furthermore, the needle's unique valve can be operated blindly, significantly reducing the risk of error. Rhino Rescue's ADV-PRO pneumothorax needle stands out as a flagship...
PR Newswire
26/10/2023

Simbec-Orion and biotx.ai launch strategic partnership to de-risk early-stage…

Fabrice Chartier, CEO at Simbec-Orion, commented: Fabrice Chartier, CEO at Simbec-Orion, commented: "We are delighted to announce our strategic partnership with biotx.ai. biotx.ai's data-driven predictions will offer our clients a cost-effective way to generate additional data to support their clinical development strategy, by utilising causal AI models to predict clinical trial outcomes and using these insights to inform clinical trial design." biotx.ai's causal AI technology...
PR Newswire
26/10/2023

New and Exciting Clinical Data on Evaxion's AI-Immunology™-Based Personalized…

Data from Evaxion's two personalized cancer vaccine clinical trials to be presented at the annual meeting of the Society for Immunotherapy of Cancer (SITC)These new sets of clinical data further strengthen Evaxion's position as a pioneering cancer vaccine companyCOPENHAGEN, Denmark, Oct.26, 2023(GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology ™ -powered vaccines, is proud...
Nasdaq GlobeNewswire
26/10/2023

COMPASS Pathways announces CFO transition

“On behalf of the Board and the company, we thank Mike for his leadership and the many contributions he made during his tenure at COMPASS,” said Kabir Nath, Chief Executive Officer of COMPASS Pathways. “He played a vital role in our recently completed private placement, which both extended the company's cash runway beyond expected key phase 3 top-line clinical data readouts and brought leading biotech investors into our shareholder base. We wish Mike continued success in his future...
Nasdaq GlobeNewswire
26/10/2023

ClariMed Company, UserWise, Expands Capabilities and Capacity in San Jose

The expanded facilities increase the number of concurrent studies UserWise can conduct while offering an enhanced onsite hosting experience and improved tech-enabled remote observation capabilities. The expanded facilities increase the number of concurrent studies UserWise can conduct while offering an enhanced onsite hosting experience and improved tech-enabled remote observation capabilities. Kelley Kendle, CEO of ClariMed, added, "The new state-of-the-art facility inSan Joseis more...
PR Newswire
26/10/2023

Burnout and poor mental health put pressure on global vitality

Stress and burnout are major contributors to this. Those with low vitality suffer more stress (9 in 10) compared to those with high vitality (7 in 10). Although these levels have declined a little since the peak of the pandemic, they remain high, with eight in 10 people suffering. Burnout remains at endemic levels, with 94% of respondents reporting at least one symptom over the past year. Stress and burnout are major contributors to this. Those with low vitality suffer more stress (9 in 10)...
PR Newswire
26/10/2023

Pharmaceutical Contract Packaging Market to Reach US$12 Billion by 2033, Driven…

NEWARK, Del., Oct. 26, 2023 /PRNewswire/ -- By the end of the year 2022, the net worth of the pharmaceutical contract packaging market was reported to have reached US$ 5.6 billion. As per our market analysis, the worldwide demand for pharmaceutical contract packaging could expand at an average of 7.5% from 2023 to 2033. By 2033, the adoption of pharmaceutical contract packaging is projected to be worth around US$ 11.9 billion, growing from US$ 6.1 billion in 2023. NEWARK, Del.,Oct...
PR Newswire
26/10/2023

Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination…

Lead formulations evaluated in the Phase 1/2 study demonstrated robust immune responses to influenza A, influenza B, and SARS-CoV-2 strains Safety profile of the mRNA-based combination vaccine candidates consistent with the companies' COVID-19 vaccineThe companies plan to start a pivotal Phase 3 trial in the coming months NEW YORK and MAINZ, GERMANY, October 26, 2023— Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive topline results from a...
Nasdaq GlobeNewswire
26/10/2023

Noster research: NOSTER and Science Microbiome Prize Symposium and Award…

The symposium on 5 October was held at NOSTER's R&D Headquarters and featured an engaging panel discussion about the prize winners' research. Participants talked about the latest advancements in understanding the complex interactions between microbial communities and their hosts, innovative research methodologies, and potential applications in medicine and sports. The symposium on 5 October was held at NOSTER's R&D Headquarters and featured an engaging panel discussion about the prize...
PR Newswire
26/10/2023

Orion Group Interim Report January–September 2023

ORION CORPORATIONINTERIM REPORT 1-9/2023 26 OCTOBER 2023 at 12:00 EESTOrion Group Interim Report January–September 2023Net sales totalled EUR 868.5 (January–September 2022: 1,046.1) million Operating profit was EUR 182.0 (398.9) millionBasic earnings per share were EUR 1.01 (2.26)Cash flow from operating activities per share was EUR 0.50 (3.05)EUR 30 million sales milestone from Nubeqa® recorded in Q3The outlook for 2023 is unchanged. Orion estimates that net...
Nasdaq GlobeNewswire
26/10/2023

World Psoriasis Day 2023: Access for All

Psoriatic disease is a painful, severe, and lifelong Noncommunicable Disease (NCD) that affects millions of individuals globally. It is also often associated with comorbidities, some of the most common being obesity, hypertension, diabetes, and cardiovascular disease – for example, people with severe psoriasis face a 46% higher risk of developing type 2 diabetes and a 58% increased likelihood of experiencing a major cardiac event.1 It is imperative that UHC health benefit packages encompass the…
PR Newswire
26/10/2023

IDP Pharma announces first patient dosed in a Phase 1/2 Clinical Trial of…

"IDP-121 has demonstrated the unique ability to directly engage cMyc protein, triggering antitumor response in several animal models. We are particularly interested in the exploration in hematological diseases, including multiple myeloma, that we know are heavily cMyc dependent and give us the opportunity to quickly measure the on-target effect. Ultimately, we hope to see biological and clinical response that will confirm the broad potential of this therapeutic approach across solid and…
PR Newswire
26/10/2023

iFR and FFR are equally safe to diagnose and treat heart disease according to…

Safety of Philips' iFR in the guidance of percutaneous coronary intervention (PCI) for heart disease demonstrated in late-breaking science at TCT 2023 highlighting patient-level outcomes analysis of 42,000 patients from the National Swedeheart Quality RegistryPrevious data demonstrate that iFR delivers consistent patient outcomes, reduces discomfort and offers a more cost-effective and faster diagnostic solution [1,2] compared to FFR Amsterdam, the Netherlands – Royal Philips ...
Nasdaq GlobeNewswire
26/10/2023

UZ Brussel PERT and Aidoc Pave the Way as First Hospital in Europe for Expedited…

"The use of the new application is a step forward in expediting the treatment of pulmonary embolisms because the artificial intelligence allows the images to be evaluated in a systematic manner according to predefined criteria," shared Frans Van den Bergh, interventional radiologist at UZ Brussel. "The use of the new application is a step forward in expediting the treatment of pulmonary embolisms because the artificial intelligence allows the images to be evaluated in a systematic…
PR Newswire
26/10/2023

Discover the Enchanting World of Chinese Life Aesthetics through Daily Ceramics…

Tangshan Longchang Ceramics Co., Ltd., has unveiled an exceptional range of bone china tableware at the Fair. The gentle and lustrous appearance, reminiscent of the exquisite beauty of jade, radiates a serene white hue that is as durable as it is resistant to wear. The designs encompassed within this range present a captivating spectacle, with options ranging from floral motifs that pay homage to the rich traditions of Chinese aesthetics, to modern geometric shapes that exude a fashionable and…
PR Newswire
26/10/2023

Lindab's Interim Report Jan - Sep 2023: Operating margin exceeded 10 percent in…

January – September 2023 January –September 2023 1) Adjusted operating profit/operating margin does not include significant one-off items and restructuring costs. Lindab's President and CEO,Ola Ringdahl, comments: "Lindab delivered a strong operating profit in the third quarter. The operating margin for the Group and both business areas exceeded 10 percent despite challenging market conditions. The cost program follows the plan, cash flow was strong and inventory levels...
PR Newswire
26/10/2023

Hansa Biopharma Interim Report January-September 2023

Highlights for the third quarter of 2023 Highlights for the third quarter of 2023 Clinical pipeline update Events after closing period Financial summary SEKm, unless otherwise stated - unaudited 9M 2022 22.8 (111.7) (254.2) (95.6) (254.0) (202.2) (442.3) (250.7) (462.5) (193.8) (392.6) 908.2 1,215.3 (62.2) 344.8 ...
PR Newswire
26/10/2023

Novozymes accelerates growth in Q3 and is on track to deliver on full-year…

After the first nine months of the 2023 financial year, Novozymes sees increasing demand for sustainable biosolutions and delivers 5% organic sales growth. The full-year organic sales growth outlook is maintained at 4-6%. COPENHAGEN, Denmark – October 26, 2023. Novozymes delivers 5% organic sales growth, an EBIT-margin of 25.5% before special items, and ROIC including goodwill of 16.3% before special items in the first nine months of the 2023 financial year. The company's full-year...
Nasdaq GlobeNewswire
26/10/2023

Mendus to participate in several investor and industry conferences in November…

Press release Stockholm, Sweden, October 26, 2023Mendus AB ("Mendus" publ; IMMU. ST), a biopharmaceutical company focused on immunotherapies targeting tumor recurrence, today announced that it will participate in the following upcoming investor and industry conferences:38th Society for the Immunotherapy of Cancer meeting (SITC 2023) San Diego, USA, November 1-5, 2023Publication of updated clinical data from the ongoing Phase 1 ALISON study with the company's lead development...
Nasdaq GlobeNewswire
26/10/2023

Interim report for 9M 2023

Please read the full announcement in PDF Attachment 2023_58_Q32023_CompanyAnnouncement
Nasdaq GlobeNewswire
26/10/2023
Altri  Comunicati